GENEVA, Oct. 30 -- ALCON INC. filed a patent application (IB2026/054103) for “DIAGNOSTIC DEVICE FOR DETECTING PKAL AND VEGF IN PATIENTS WITH RETINAL VASCULATURE DISEASE”. With publication no. WO/2026/... Read More
GENEVA, Oct. 30 -- ALCON INC. filed a patent application (IB2026/054094) for “INTRAOCULAR LENS SIMULATOR”. With publication no. WO/2026/224685, here are the other details related to the patent applica... Read More
GENEVA, Oct. 30 -- INV POLYPROPYLENE, LLC filed a patent application (IB2026/054096) for “LOW BINDING POLYPROPYLENE”. With publication no. WO/2026/224687, here are the other details related to the pat... Read More
GENEVA, Oct. 30 -- ALCON, INC. filed a patent application (IB2026/054099) for “AUTOMATED TROCAR PLACEMENT GUIDANCE FOR SURGICAL PROCEDURES”. With publication no. WO/2026/224688, here are the other det... Read More
GENEVA, Oct. 30 -- MULTITUDE THERAPEUTICS INC. filed a patent application (IB2026/054081) for “STABLE FORMULATIONS FOR AN ANTIBODY-DRUG CONJUGATE DIRECTED AGAINST CD142”. With publication no. WO/2026/... Read More
GENEVA, Oct. 30 -- SANOFI filed a patent application (IB2026/054087) for “EXPRESSION CONSTRUCTS FOR PRODUCING RECOMBINANT ANTIBODIES”. With publication no. WO/2026/224682, here are the other details r... Read More
GENEVA, Oct. 30 -- AFFINIA THERAPEUTICS INC. filed a patent application (IB2026/054090) for “RECOMBINANT AAVS WITH IMPROVED TROPISM AND SPECIFICITY”. With publication no. WO/2026/224683, here are the ... Read More
GENEVA, Oct. 30 -- ALCON INC. filed a patent application (IB2026/054092) for “ERODIBLE INTRAOCULAR PKAL INHIBITOR IMPLANTS AND USES THEREOF”. With publication no. WO/2026/224684, here are the other de... Read More
GENEVA, Oct. 30 -- IRCCS OSPEDALE POLICLINICO SAN MARTINO filed a patent application (IB2026/054067) for “NON-COVALENT STAT3 INHIBITOR ANTITUMOR AGENT”. With publication no. WO/2026/224678, here are t... Read More
GENEVA, Oct. 30 -- MULTITUDE THERAPEUTICS INC. filed a patent application (IB2026/054076) for “SAFE AND EFFICACIOUS DOSING REGIMENS FOR AN ANTIBODY-DRUG CONJUGATE DIRECTED AGAINST CD142”. With publica... Read More